Prevention and Control

The occurrence of infectious diseases is influenced by a wide range of interconnected factors that determine how pathogens emerge, spread, and persist within populations. Changes in climate, environmental conditions, human behavior, global travel, urban expansion, population movement, and microbial adaptation all contribute to the changing patterns of infectious disease transmission. Understanding these drivers is essential for identifying populations at risk, improving disease prediction, strengthening prevention strategies, and developing effective public health interventions. This track provides a platform to explore the scientific evidence behind disease emergence, transmission dynamics, host susceptibility, environmental influences, and innovative approaches for reducing the global burden of infectious diseases.

Market Analysis: The global infectious disease surveillance and prevention market is estimated at USD 31.5 billion in 2025 and is anticipated to reach nearly USD 52.8 billion by 2030, expanding at a CAGR of 10.9%. Increasing investments in integrated surveillance systems, digital epidemiology, genomic sequencing, and AI-driven outbreak forecasting are reshaping the market. Government initiatives aimed at strengthening health security, along with growing international collaboration for monitoring emerging and re-emerging infections, continue to drive innovation. While North America maintains a leading market position through advanced public health infrastructure, the Asia-Pacific region is expected to record the highest growth owing to expanding healthcare capacity, improved surveillance networks, and increasing investments in infectious disease preparedness.

ALSO READ Infectious Diseases and Global Health Viral Infections Bacterial Infections Fungal Infections Vector-borne Diseases Virology and HIVAIDS Immunology and Clinical Microbiology Antiviral Drug Resistance Catheter-Associated Urinary Tract Infection Emerging Infectious Diseases Hospital-Acquired Infections HAIs Maternal-Fetal Infections Next-Generation Antibiotics Pediatric Infectious Diseases Sepsis Diagnosis and Care Zoonotic Diseases Neurological and CNS Infections Healthcare-Associated Infections Ophthalmological Infectious Diseases Lower Respiratory and Pediatric IDs Genomics and Infectious disease Special Session on COVID-19 Vaccines and Immunizations Antibiotic Sensitivity Testing Blood-Borne Disease Contagious Disease Encephalitis Global Pandemic Preparedness Influenza Surveillance Systems Microbiome and Immunity Occupational Safety and Health OSH Point-of-Care Testing POCT Travel-Related Infections Tropical Diseases and Parasitic Diseases Sexually Transmitted Diseases and STIs Pathophysiology and Diagnosis Clinical Trials and Case Studies Influencing Factors of IDs Advanced Treatments and Technologies Oral and Maxillofacial Infections Prevention and Control Public Health and Epidemiology Artificial Intelligence in ID Climate Change and Infections Gastroenteritis HIV and Co-Infections Malaria Elimination Strategies Neglected Tropical Diseases NTDs One Health Approach Rapid Diagnostic Innovations Tuberculosis Drug Resistance

Tags
Infectious Disease Conferences Microbiology Conferences Infectious Disease Conferences USA Entomology Conferences HIV/AIDS Conferences Infectious Diseases Conferences Public Health Conferences Virology Conferences Epidemiology Conferences Infectious Diseases Conferences Europe Parasitology Conferences Infection Conferences 2027 Vector-Borne Diseases Conferences Pathology Conferences Infectious Disease Conferences 2026 Asia

+1 (506) 909-0537